Armistice Capital, LLC Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$120.4 - $237.13 $14.4 Million - $28.5 Million
120,000 Added 75.0%
280,000 $64.8 Million
Q3 2023

Nov 14, 2023
BUY
$146.04 - $225.78 $23.4 Million - $36.1 Million
160,000 New
160,000 $23.4 Million
Q1 2023

May 15, 2023
BUY
$231.06 - $307.08 $28.9 Million - $38.4 Million
125,000 New
125,000 $30.3 Million

Others Institutions Holding MDGL

# of Institutions
295
Shares Held
21.9M
Call Options Held
819K
Put Options Held
644K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.61B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email